Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5649-5658

  Foldenauer, Megan E B ^a   McClellan, Sharon A ^a   Berger, Elizabeth A ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CCAAT ENHANCER BINDING PROTEIN BETA; GAMMA INTERFERON; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 10; INTERLEUKIN 12P40; MAMMALIAN TARGET OF RAPAMYCIN; PREPROTACHYKININ; RAPAMYCIN; RECOMBINANT INTERLEUKIN 10; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; BACTERIAL KERATITIS; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; ENZYME INHIBITION; FEMALE; GENE CONTROL; GENE MUTATION; IMMUNOREGULATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BACTERIAL LOAD; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-10; KERATITIS; MICE; NEUTROPHIL INFILTRATION; NEUTROPHILS; NITRITES; PEROXIDASE; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RNA, MESSENGER; SIROLIMUS; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TOR SERINE-THREONINE KINASES;

EID: 84878100415     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203094     Document Type: Article

References (32)

1. McClellan, S. A., X. Huang, R. P. Barrett, N. van Rooijen, and L. D. Hazlett. 2003. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice. J. Immunol. 170: 5219-5227. (Pubitemid 36554755)
2. McClellan, S. A., Y. Zhang, R. P. Barrett, and L. D. Hazlett. 2008. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated. Invest. Ophthalmol. Vis. Sci. 49: 1502-1511.
3. Baker, A. K., R. Wang, N. Mackman, and J. P. Luyendyk. 2009. Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-α expression in macrophages by reducing IL-10 expression. Mol. Immunol. 46: 2249-2255.
4. Cheekatla, S. S., A. Aggarwal, and S. Naik. 2012. mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection. Med. Microbiol. Immunol. (Berl.) 201: 37-46.
5. Weichhart, T., G. Costantino, M. Poglitsch, M. Rosner, M. Zeyda, K. M. Stuhlmeier, T. Kolbe, T. M. Stulnig, W. H. Hörl, M. Hengstschläger, et al. 2008. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29: 565-577.
6. Thomson, A. W., H. R. Turnquist, and G. Raimondi. 2009. Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9: 324-337.
7. Yang,Q., and K. L.Guan. 2007. ExpandingmTOR signaling. Cell Res. 17: 666-681.
8. Webster, A. C., V. W. Lee, J. R. Chapman, and J. C. Craig. 2006. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation 81: 1234-1248.
9. Säemann, M. D., M. Haidinger, M. Hecking, W. H. Hörl, and T. Weichhart. 2009. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am. J. Transplant. 9: 2655-2661.
10. Schmitz, F., A. Heit, S. Dreher, K. Eisenächer, J. Mages, T. Haas, A. Krug, K. P. Janssen, C. J. Kirschning, and H. Wagner. 2008. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 38: 2981-2992.
11. Hazlett, L. D., X. L. Rudner, S. A. McClellan, R. P. Barrett, and S. Lighvani. 2002. Role of IL-12 and IFN-γ in Pseudomonas aeruginosa corneal infection. Invest. Ophthalmol. Vis. Sci. 43: 419-424. (Pubitemid 34113224)
12. Zhou, Z., R. P. Barrett, S. A. McClellan, Y. Zhang, E. A. Szliter, N. van Rooijen, and L. D. Hazlett. 2008. Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection. Invest. Ophthalmol. Vis. Sci. 49: 4458-4467.
13. Hazlett, L. D., M. M. Moon, M. Strejc, and R. S. Berk. 1987. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest. Ophthalmol. Vis. Sci. 28: 1978-1985. (Pubitemid 18019956)
14. Williams, R. N., C. A. Patterson, and K. E. Eakins. 1982. Quantification of ocular inflammation: evaluation of polymorphonuclear leukocyte inflammation by measuring myeloperoxidase activity. Curr. Eye Res. 2: 465-470. (Pubitemid 13061853)
15. Luo, Y., and M. E. Dorf. 1997. Isolation of mouse neutrophils. Curr. Protoc. Immunol. Chapter 3: Unit 3.20.
16. Szliter, E. A., S. Lighvani, R. P. Barrett, and L. D. Hazlett. 2007. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. J. Immunol. 178: 1105-1114. (Pubitemid 46098857)
17. Hazlett, L. D., S. A. Masinick-McClellan, and R. P. Barrett. 1999. Complement defects in aged mice compromise phagocytosis of Pseudomonas aeruginosa. Curr. Eye Res. 19: 26-32. (Pubitemid 29308826)
18. Yu, S. Y., L. Liu, P. U. Li, and J. Li. 2012. Rapamycin inhibits the mTOR/p70S6K pathway and attenuates cardiac fibrosis in adriamycin-induced dilated cardiomyopathy. Thorac. Cardiovasc. Surg. 10.1055/s-0032-1311548.
19. + T cells. Blood 111: 453-462.
20. Weiner, S. M., L. Sellin, O. Vonend, P. Schenker, N. J. Buchner, M. Flecken, R. Viebahn, and L. C. Rump. 2007. Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome: a single-centre experience and review of the literature. Nephrol. Dial. Transplant. 22: 3631-3637. (Pubitemid 350212488)
21. Rolas, L., N. Makhezer, S. Hadjoudj, J. El-Benna, B. Djerdjouri, L. Elkrief, R. Moreau, and A. Périanin. 2013. Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated cirrhotic patients. Hepatology 57: 1163-1171.
22. Berlato, C., M. A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni. 2002. Involvement of suppressor of cytokine signaling-3 (SOCS3) as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168: 6404-6411. (Pubitemid 34620065)
23. Qin, H., W. I. Yeh, P. De Sarno, A. T. Holdbrooks, Y. Liu, M. T. Muldowney, S. L. Reynolds, L. L. Yanagisawa, T. H. Fox, III, K. Park, et al. 2012. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc. Natl. Acad. Sci. USA 109: 5004-5009.
24. McClellan, S. A., X. Huang, R. P. Barrett, S. Lighvani, Y. Zhang, D. Richiert, and L. D. Hazlett. 2006. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection. Invest. Ophthalmol. Vis. Sci. 47: 256-264. (Pubitemid 46780822)
25. Hazlett, L. D., S. McClellan, C. Goshgarian, X. Huang, A. Thakur, and R. Barrett. 2005. The role of nitric oxide in resistance to P. aeruginosa ocular infection. Ocul. Immunol. Inflamm. 13: 279-288. (Pubitemid 41702770)
26. McClellan, S. A., S. Lighvani, and L. D. Hazlett. 2006. IFN-g: regulation of nitric oxide in the P. aeruginosa-infected cornea. Ocul. Immunol. Inflamm. 14: 21-28. (Pubitemid 43336315)
27. Sun, Y., M. Karmakar, S. Roy, R. T. Ramadan, S. R. Williams, S. Howell, C. L. Shive, Y. Han, C. M. Stopford, A. Rietsch, and E. Pearlman. 2010. TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways. J. Immunol. 185: 4272-4283.
28. Huang, X., W. Du, S. A. McClellan, R. P. Barrett, and L. D. Hazlett. 2006. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 47: 4910-4916. (Pubitemid 46586392)
29. Kovács, K. A., M. Steinmann, P. J. Magistretti, O. Halfon, and J. R. Cardinaux. 2006. C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones. J. Neurochem. 98: 1390-1399. (Pubitemid 44200431)
30. Foldenauer, M. E., S. A. McClellan, and L. D. Hazlett. mTOR inhibition: similarity to treatment with substance P in Pseudomonas infection. Poster session presented at: The Association for Research in Vision and Opthalmology; 2012 May 6; Fort Lauderdale, FL.
31. Ren, Y., and J. Savill. 1998. Apoptosis: the importance of being eaten. Cell Death Differ. 5: 563-568. (Pubitemid 28356577)
32. Rowe, S. J., L. Allen, V. C. Ridger, P. G. Hellewell, and M. K. Whyte. 2002. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J. Immunol. 169: 6401-6407. (Pubitemid 36903489)